Dr. Hyung-Goo Kim studied chemistry (BS) and biochemistry (MS) at the University of Goettingen in Germany. He received his PhD from the Free University of Berlin in conjunction with the Max Planck Institute for Molecular Genetics. In previous work, Dr. Kim successfully employed positional cloning and candidate gene approaches to identify disease genes. This resulted in the identification of four novel disease genes: NRXN1 for autism and PHF21A for intellectual disability, combined with craniofacial anomalies. He also identified two novel disease genes, WDR11 and CHD7, in Kallmann syndrome, characterized by anosmia and delayed puberty. Each finding marked a major contribution to the field of human molecular genetics. After working on the Developmental Genome Anatomy Project (DGAP) under Dr. James Gusella at Harvard Medical School for 5 years, Dr. Kim became an associate professor at the Medical College of Georgia, Augusta University, US, from 2013 to 2018. To identify disease genes in neurodevelopmental disorders, including autism and intellectual disability, he later moved to the Middle East. He focuses on identifying new disease genes in consanguineous countries, including Qatar and Oman, to elucidate their mechanisms for accurate molecular diagnosis, better prognosis, and the eventual development of medical and therapeutic interventions. He has been working on positional cloning and next-generation sequencing for human developmental disorders for the last 25 years.